/
DEVELOPMENT OF BUSINESS Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott s* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products.
$86.67
$0.74 (-0.85%)
Price from 8 days ago
18.17% operating margin is respectable but not wide. ROIC at 9.46%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 5.7%, steady but not accelerating.
Even for strong businesses, today's 24x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
24.3x earnings, 20.5x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$45.13B
▲ +5.7% YoY
Net Income (TTM)
$6.28B
▼ -51.3% YoY
Op. Margin
17.07%
▲ +1.9pp YoY
ROIC
8.34%
▲ +0.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$7.38B
▲ +16.4% YoY
Op. Cash Flow (TTM)
$9.46B
▲ +11.8% YoY
Net Debt
$26.75B
Cash & Equiv.
$7.29B
5Y CAGR: +5.1%
5Y CAGR: +5.3%
Continue Research